How High Could IBIT Go?
Recently, a surprising number of billionaire hedge fund managers have…
Sell
38
ASND Quote, Financials, Valuation and Earnings
Last price:
$155.92
Seasonality move
:
-2.92%
Day range:
$143.81 - $156.96
52-week range:
$111.09 - $169.37
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
23.02x
P/B ratio:
--
Volume:
532K
Avg. volume:
460.5K
1-year change:
3.1%
Market cap:
$9.4B
Revenue:
$393.6M
EPS (TTM):
-$7.13
Earnings Data
Next earnings date for ASND
May 02
2025
Most recent earnings per share
-$0.68
Beat by $0.28
(Feb 12/2025)
Consensus Estimate
-$0.96
(Feb 12/2025)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
ASND Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 06/30/2025 | Q2 | $137.1M | -- | -- | -$1.43 | -- |
| 05/02/2025 | Q1 | $102.6M | -- | -- | -$1.64 | -- |
| 02/12/2025 | Q4 | $123.2M | $185.4M | -$0.68 | -$0.96 | $0.28 |
| 11/14/2024 | Q3 | $76.5M | $63.6M | -$1.89 | -$1.57 | -$0.32 |
| 09/03/2024 | Q2 | $94.2M | $38.8M | -$2.06 | -$1.40 | -$0.65 |
| 05/02/2024 | Q1 | $85.6M | $104.2M | -$2.50 | -$1.52 | -$0.98 |
| 02/07/2024 | Q4 | $92.1M | $148.3M | -$1.66 | -$1.90 | $0.24 |
| 11/07/2023 | Q3 | -- | -- | -$3.14 | -$2.37 | -$0.76 |
| 09/05/2023 | Q2 | -- | -- | -$2.36 | -$2.80 | $0.45 |
| 04/27/2023 | Q1 | -- | -- | -$2.13 | -$2.89 | $0.77 |
| 02/16/2023 | Q4 | -- | -- | -$3.78 | -$2.77 | -$1.02 |
| 11/02/2022 | Q3 | -- | -- | -$3.05 | -$2.52 | -$0.53 |
| 08/10/2022 | Q2 | -- | -- | -$1.56 | -$2.28 | $0.73 |
| 05/11/2022 | Q1 | -- | -- | -$2.48 | -$2.15 | -$0.33 |
| 03/02/2022 | Q4 | -- | -- | -$2.14 | -$2.59 | $0.46 |
| 11/10/2021 | Q3 | -- | -- | -- | -$2.66 | -- |
| 08/25/2021 | Q2 | -- | -- | -$3.01 | -$2.64 | -$0.37 |
| 05/27/2021 | Q1 | -- | -- | -$1.41 | -$2.27 | $0.86 |
| 03/10/2021 | Q4 | -- | -- | -$3.15 | -$1.88 | -$1.27 |
| 11/11/2020 | Q3 | -- | -- | -$2.70 | -$1.87 | -$0.83 |
| 08/27/2020 | Q2 | -- | -- | -$2.17 | -$1.60 | -$0.57 |
| 05/19/2020 | Q1 | -- | -- | -$1.46 | -$1.40 | -$0.05 |
| 12/31/2019 | Q4 | -- | -- | -$1.88 | -$1.32 | -$0.56 |
| 11/18/2019 | Q3 | -- | -- | -$0.59 | -$1.28 | $0.69 |
| 08/28/2019 | Q2 | -- | -- | -- | -$1.33 | -- |
| 04/03/2019 | Q1 | -- | -- | -- | -$1.14 | -- |
| 12/31/2018 | Q4 | -- | -- | -- | -$1.13 | -- |
| 11/28/2018 | Q3 | -- | -- | -- | -$1.20 | -- |
| 08/29/2018 | Q2 | -- | -- | -- | -$0.99 | -- |
| 05/30/2018 | Q1 | -- | -- | -- | -- | -- |
| 03/28/2018 | Q4 | -- | -- | -- | -- | -- |
| 11/16/2017 | Q3 | -- | -- | -- | -- | -- |
| 08/18/2017 | Q2 | -- | -- | -- | -- | -- |
| 03/31/2017 | Q1 | -- | -- | -- | -- | -- |
| 12/31/2016 | Q4 | -- | -- | -- | -- | -- |
| 11/30/2016 | Q3 | -- | -- | -- | -- | -- |
| 08/31/2016 | Q2 | -- | -- | -- | -- | -- |
| 03/31/2016 | Q1 | -- | -- | -- | -- | -- |
| 12/31/2015 | Q4 | -- | -- | -- | -- | -- |
| 09/30/2015 | Q3 | -- | -- | -- | -- | -- |
| 06/30/2015 | Q2 | -- | -- | -- | -- | -- |
Ascendis Pharma AS Earnings Questions
-
How Much did Ascendis Pharma AS Generate in Revenue Last Quarter?
Ascendis Pharma AS reported $185.4M worth of top line sales in its most recent quarter.
-
Did Ascendis Pharma AS Beat Earnings Last Quarter?
Ascendis Pharma AS announced earnings per share of -$0.68 which represents a beat of analyst forecast a -$0.96 per share.
-
Is Ascendis Pharma AS Profitable?
Ascendis Pharma AS reported $170.4M that represents $2.85 per share over the last quarter.
-
What is the Analyst Consensus for Ascendis Pharma AS EPS Next Year?
Ascendis Pharma AS's earnings are forecast to decrease from -$7.07 per share to -$6.78 per share next year representing a decrease of -49.27%.
-
When is Ascendis Pharma AS's Earnings Date?
Ascendis Pharma AS's next earnings date is May 2, 2025.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Raymond James Stock a Buy, Sell or Hold?
Raymond James Financial (NYSE:RJF) is one of America’s large financial…
Is JHX Stock a Buy Sell or Hold?
James Hardie Industries (NYSE:JHX) is a manufacturer of outside building…
Stock Ideas
Buy
56
Is AAPL Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 37x
Sell
46
Is MSFT Stock a Buy?
Market Cap: $2.8T
P/E Ratio: 32x
Sell
41
Is NVDA Stock a Buy?
Market Cap: $2.6T
P/E Ratio: 37x
Alerts
Buy
80
CORT alert for Apr 1
Corcept Therapeutics [CORT] is up 109.21% over the past day.
Sell
47
RGC alert for Apr 1
Regencell Bioscience Holdings [RGC] is up 26.1% over the past day.
Buy
74
COOP alert for Apr 1
Mr. Cooper Group [COOP] is up 14.4% over the past day.
